Is the urea cycle involved in Alzheimer's disease?

Journal of Alzheimer's Disease

Volumn 21, Issue 3, 2010, Pages 1013-1021

  Hansmannel, Franck ^a,b   Sillaire, Adeline ^a,b   Kamboh, M Ilyas ^c   Lendon, Corinne ^d   Pasquier, Florence ^a,e   Hannequin, Didier ^f   Laumet, Geoffroy ^a,b   Mounier, Anais ^a,b   Ayral, Anne Marie ^a,b   Dekosky, Steven T ^g   Hauw, Jean Jacques ^h   Berr, Claudine ⁱ   Mann, David ^j   Amouyel, Philippe ^a,b,e   Campion, Dominique ^f   Lambert, Jean Charles ^a,b  

^a INSTITUT PASTEUR DE LILLE   (France)

^b UNIV LILLE   (France)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^e LILLE UNIVERSITY HOSPITAL   (France)

^f INSERM   (France)

^g UNIVERSITY OF VIRGINIA   (United States)

^h INSTITUT DU CERVEAU ET DE LA MOELLE ÉPINIÈRE   (France)

ⁱ UNIV MONTPELLIER   (France)

^j UNIVERSITY OF MANCHESTER   (United Kingdom)

more..

Author keywords

Alzheimer's disease; ammonium; arginase; association study; citrulline NO cycle; nitric oxide; polyamines; urea cycle

Indexed keywords

ARGINASE; ARGINASE 2; GLUTAMATE AMMONIA LIGASE; UNCLASSIFIED DRUG;

AGED; ALLELISM; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC RISK; GENOTYPE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; UREA CYCLE;

EID: 77957259704     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2010-100630     Document Type: Article

References (35)

1. Caselli RJ, Beach TG, Yaari R, Reiman EM (2006) Alzheimer's disease a century later. J Clin Psychiatry 67, 17841800. (Pubitemid 44955162)
2. Goedert M, Spillantini MG (2006) A century of Alzheimer's disease. Science 314, 777781. (Pubitemid 44706636)
3. Cruts M, Van Broeckhoven C (1998) Molecular genetics of Alzheimer's disease. Ann Med 30, 560565. (Pubitemid 29012304)
4. Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R,Myers RH, PericakVance MA, Risch N, Van Duijn CM(1997) Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A metaanalysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 278, 13491356.
5. Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Williams A, Jones N, Thomas C, Stretton A, Morgan AR, Lovestone S, Powell J, Proitsi P, Lupton MK, Brayne C, Rubinsztein DC, Gill M, Lawlor B, Lynch A, Morgan K, Brown KS, Passmore PA, Craig D, McGuinness B, Todd S, Holmes C, Mann D, SmithAD, Love S,Kehoe PG,Hardy J,Mead S, FoxN,Rossor M, Collinge J, Maier W, Jessen F, Schurmann B, Van Den BH, Heuser I, Kornhuber J, Wiltfang J, Dichgans M, Frolich L, Hampel H, Hull M, Rujescu D, Goate AM, Kauwe JS, Cruchaga C, Nowotny P, Morris JC, Mayo K, Sleegers K, Bettens K, Engelborghs S, De Deyn PP, Van Broeckhoven C, Livingston G, Bass NJ, Gurling H, McQuillin A, Gwilliam R, Deloukas P,AlChalabiA, ShawCE, TsolakiM, SingletonAB, Guerreiro R, Muhleisen TW, Nothen MM, Moebus S, Jockel KH, Klopp N, Wichmann HE, Carrasquillo MM, Pankratz VS, Younkin SG, Holmans PA, O'Donovan M, Owen MJ, Williams J (2009) Genomewide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet 41, 10881093.
6. Lambert JC, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, Combarros O, Zelenika D, Bullido MJ, Tavernier B, Letenneur L, Bettens K, Berr C, Pasquier F, Fievet N, BarbergerGateau P, Engelborghs S, De Deyn P, Mateo I, Franck A, Helisalmi S, Porcellini E, Hanon O, De Pancorbo MM, Lendon C, Dufouil C, Jaillard C, Leveillard T,Alvarez V, Bosco P, Mancuso M, Panza F, Nacmias B, Bossu P, Piccardi P, Annoni G, Seripa D, Galimberti D, Hannequin D, Licastro F, Soininen H, Ritchie K, Blanche H, Dartigues JF, Tzourio C, Gut I, Van Broeckhoven C, Alperovitch A, Lathrop M, Amouyel P (2009) Genomewide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet 41, 10941099.
7. Bensemain F, Hot D, Ferreira S, Dumont J, Bombois S, Maurage CA, Huot L, Hermant X, Levillain E, Hubans C, Hansmannel F, Chapuis J, Hauw JJ, Schraen S, Lemoine Y, Buee L, Berr C, Mann D, Pasquier F, Amouyel P, Lambert JC (2009) Evidence for induction of the ornithine transcarbamylase expression in Alzheimer's disease. Mol Psychiatry 14, 106116.
8. Hansmannel F, Lendon C, Pasquier F, Dumont J, Hannequin D, Chapuis J, Laumet G, Ayral AM, Galimberti D, Scarpini E, Campion D, Amouyel P, Lambert JC (2009) Is the ornithine transcarbamylase gene a genetic determinant of Alzheimer's disease? Neurosci Lett 449, 7680.
9. Takiguchi M, Mori M (1995) Transcriptional regulation of genes for ornithine cycle enzymes. Biochem J 312, 649659. (Pubitemid 26005969)
10. Chapuis J, Hot D, Hansmannel F, Kerdraon O, Ferreira S, Hubans C, Maurage CA, Huot L, Bensemain F, Laumet G, Ayral AM, Fievet N, Hauw JJ, Dekosky ST, Lemoine Y, Iwatsubo T, WavrantDevrieze F, Dartigues JF, Tzourio C, Buee L, Pasquier F, Berr C, Mann D, Lendon C, Alperovitch A, Kamboh MI, Amouyel P, Lambert JC (2009) Transcriptomic and genetic studies identify IL33 as a candidate gene for Alzheimer's disease. Mol Psychiatry 14, 10041016.
11. BerrC, Lambert JC, SazdovitchV,Amouyel P, ChartierHarlin MC, Mohr M, Heldt N, Kiesmann M, Hauw JJ (2001) Neuropathological epidemiology of cerebral aging: A study of two genetic polymorphisms. Neurobiol Aging 22, 227235. (Pubitemid 32162971)
12. Chapuis J, Moisan F, Mellick G, Elbaz A, Silburn P, Pasquier F, Hannequin D, Lendon C, Campion D, Amouyel P, Lambert JC (2008) Association study of the NEDD9 gene with the risk of developing Alzheimer's and Parkinson's disease. Hum Mol Genet 17, 28632867.
13. Schaid DJ, Jacobsen SJ (1999) Biased tests of association: Comparisons of allele frequencieswhen departing fromHardyWeinberg proportions. Am J Epidemiol 149, 706711.
14. Breslow NE, Day NE, Halvorsen KT, Prentice RL, Sabai C (1978) Estimation of multiple relative risk functions in match ed casecontrol studies. Am J Epidemiol 108, 299307.
15. LiH,Wetten S, Li L, St Jean PL,Upmanyu R, Surh L,Hosford D, Barnes MR, Briley JD, Borrie M, Coletta N, Delisle R, Dhalla D, Ehm MG, Feldman HH, Fornazzari L, Gauthier S, Goodgame N, Guzman D, Hammond S, Hollingworth P, Hsiung GY, Johnson J, Kelly DD, Keren R, Kertesz A, King KS, Lovestone S, LoyEnglish I,Matthews PM, OwenMJ, Plumpton M, PrysePhillips W, Prinjha RK, Richardson JC, Saunders A, Slater AJ, GeorgeHyslop PH, Stinnett SW, Swartz JE, Taylor RL, Wherrett J, Williams J, Yarnall DP, Gibson RA, Irizarry MC, Middleton LT, Roses AD (2008) Candidate singlenucleotide polymorphisms from a genomewide association study of Alzheimer disease. Arch Neurol 65, 4553.
16. Reiman EM,Webster JA,Myers AJ,Hardy J, Dunckley T, Zismann VL, Joshipura KD, Pearson JV, HuLince D, Huentelman MJ, Craig DW, Coon KD, LiangWS, Herbert RH, Beach T, Rohrer KC, Zhao AS, Leung D, Bryden L, Marlowe L, Kaleem M, Mastroeni D, Grover A, Heward CB, Ravid R, Rogers J, Hutton ML, Melquist S, Petersen RC, Alexander GE, Caselli RJ, Kukull W, Papassotiropoulos A, Stephan DA (2007) GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers. Neuron 54, 713720. (Pubitemid 46843528)
17. Morris SM, Jr., Bhamidipati D, KepkaLenhart D (1997) Human type II arginase: sequence analysis and tissuespecific expression. Gene 193, 157161. (Pubitemid 27294602)
18. NeillMA, Aschner J, Barr F, SummarML (2009) Quantitative RTPCR comparison of the urea and nitric oxide cycle gene transcripts in adult human tissues. Mol Genet Metab 97, 121127.
19. Ober C, Loisel DA, Gilad Y (2008) Sexspecific genetic architecture of human disease. Nat Rev Genet 9, 911922. (Pubitemid 50329067)
20. Zou F, Gopalraj RK, Lok J, Zhu H, Ling IF, Simpson JF, Tucker HM, Kelly JF, Younkin SG, Dickson DW, Petersen RC, GraffRadford NR, Bennett DA, Crook JE, Younkin SG, Estus S (2008) Sexdependent association of a common lowdensity lipoprotein receptor polymorphism with RNA splicing efficiency in the brain and Alzheimer's disease. Hum Mol Genet 17, 929935. (Pubitemid 351426027)
21. Calabrese V, Mancuso C, Calvani M, Rizzarelli E, Butterfield DA, Stella AM (2007) Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity. Nat Rev Neurosci 8, 766775. (Pubitemid 47462116)
22. Estevez AG, Sahawneh MA, Lange PS, Bae N, EgeaM, Ratan RR (2006) Arginase 1 regulation of nitric oxide production is key to survival of trophic factordeprived motor neurons. J Neurosci 26, 85128516. (Pubitemid 44316179)
23. Lange PS, Langley B, Lu P, Ratan RR (2004) Novel roles for arginase in cell survival, regeneration, and translation in the central nervous system. J Nutr 134, 2812S2817.S. (Pubitemid 39315227)
24. Smith CD, Carney JM, StarkeReed PE, Oliver CN, Stadtman ER, Floyd RA, Markesbery WR (1991) Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proc Natl Acad Sci USA 88, 1054010543.
25. Felipo V, Butterworth RF (2002) Neurobiology of ammonia. Prog Neurobiol 67, 259279. (Pubitemid 35229984)
26. Seiler N (2002) Ammonia and Alzheimer's disease. Neurochem Int 41, 189207. (Pubitemid 34521692)
27. Suarez I,Bodega G, Fernandez B(2002)Glutamine synthetase in brain: effect of ammonia. Neurochem Int 41, 123142. (Pubitemid 34521686)
28. Mori M (2007) Regulation of nitric oxide synthesis and apoptosis by arginase and arginine recycling. J Nutr 137, 1616S1620.S. (Pubitemid 46855520)
29. Morris SM, Jr. (2007) Arginine metabolism: boundaries of our knowledge. J Nutr 137, 1602S1609.S.
30. Nelin LD, Wang X, Zhao Q, Chicoine LG, Young TL, Hatch DM, English BK, Liu Y (2007) MKP1 switches arginine metabolism from nitric oxide synthase to arginase following endotoxin challenge. Am J Physiol Cell Physiol 293, C632C640. (Pubitemid 47235185)
31. Wallace HM, Fraser AV, Hughes A (2003) A perspective of polyamine metabolism. Biochem J 376, 114.
32. Malaterre J, Strambi C, Aouane A, Strambi A, Rougon G, Cayre M (2004) A novel role for polyamines in adult neurogenesis in rodent brain. Eur J Neurosci 20, 317330. (Pubitemid 38969617)
33. Morrison B, III, Pringle AK, McManus T, Ellard J, Bradley M, Signorelli F, Iannotti F, Sundstrom LE (2002) Larginyl3,4spermidine is neuroprotective in several in vitro models of neurodegeneration and in vivo ischaemia without suppressing synaptic transmission. Br J Pharmacol 137, 12551268. (Pubitemid 36071743)
34. Pringle AK,Morrison B, III, BradleyM, Iannotti F, Sundstrom LE (2003) Characterisation of a novel class of polyaminebased neuroprotective compounds. Naunyn Schmiedebergs Arch Pharmacol 368, 216224. (Pubitemid 37255483)
35. Nilsson T, Bogdanovic N, Volkman I, Winblad B, Folkesson R, Benedikz E (2006) Altered subcellular localization of ornithine decarboxylase in Alzheimer's disease brain. Biochem Biophys Res Commun 344, 640646.